Karbamazepin Tillomed (Carbamazepine)

Carbamazepine blocks voltage‑gated sodium channels on neurons, which reduces the rapid influx of sodium during depolarisation. This stabilises hyper‑excited neuronal membranes, limits repetitive firing, and diminishes the transmission of excitatory impulses that underlie seizures and neuropathic pain.

The dosage of carbamazepine is individualized. A qualified prescriber determines the appropriate starting dose, titration schedule, and maintenance dose based on the patient’s age, weight, renal and hepatic function, and therapeutic response. Patients should follow the prescribing clinician’s instructions precisely.

Carbamazepine is classified as Pregnancy Category D, indicating evidence of risk to the fetus. It should be used only when the potential benefit justifies the risk. The drug is excreted in breast milk; nursing mothers should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Carbamazepine is a sodium‑channel blocker, whereas many newer anticonvulsants act on calcium channels, GABA receptors, or glutamate pathways. Compared with drugs like levetiracetam, carbamazepine has a well‑established efficacy for focal seizures but may have more drug‑interaction potential due to enzyme induction.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Karbamazepin Tillomed is taken orally, usually with food or a glass of water to minimise gastrointestinal irritation. The tablet should be swallowed whole and not crushed or chewed unless the prescriber advises otherwise.

Serious adverse events include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias like agranulocytosis or aplastic anemia, and hepatic failure. Patients should be instructed to seek immediate medical attention for rash, fever, jaundice, or unexplained bruising.

Patients with known hypersensitivity to carbamazepine or any of its excipients, those with a history of bone marrow suppression, severe hepatic impairment, or uncontrolled cardiac arrhythmias should avoid this medication. Additionally, it is contraindicated in individuals taking monoamine oxidase inhibitors within 14 days.